// App-Quantinova.ai

3070 : Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour?

Researchers

Presenter

  • Thierry Landre

Principal Investigators

  • Cherifa Taleb

  • Patrick Nicolas

  • Gaetan Des Guetz

Medical Centers

  • Hopital Rene Muret, HUPSSD, UCOG 93 (APHP), Sevran, France

  • Hopital Rene Muret, HUPSSD, Geriatric Oncology Unit (APHP), Sevran, France

  • Hopital Avicenne, HUPSSD, Paris 13, Bobigny, France

  • Service d'Oncologie Medicale, CHU Limoges, Limoges, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final